What we found on the web about BristolMyers
Bristol-Myers Squibb - Wikipedia, the free encyclopedia
Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical company. Founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY ...
Ipilimumab - Wikipedia, the free encyclopedia
Ipilimumab (also known as MDX-010 or MDX-101) is a human monoclonal antibody being developed by Bristol-Myers Squibb and Medarex. It is intended to be used as a drug to activate ...
BMY Quote - BMY Stock Quote - Bristol-Myers Squibb Co. Stock Quote ...
NYSE and Amex prices are delayed at least 20 minutes and Nasdaq prices are delayed at least 15 minutes. Volume updates until 8:00 p.m. ET. Real-Time Quotes
Bristol-Myers Squibb Children's Hospital
The Bristol-Myers Squibb Children's Hospital provides a full range of pediatric specialties in a family centered, child friendly environment. The children's hospital is located in ...
Bristol-Myers Squibb - Home
Bristol-Myers Squibb is a global pharmaceutical company whose mission is to extend and enhance human life by developing innovative medicines and health care products.
Bristol-Myers Squibb España
Bristol-Myers Squibb es una compañia farmaceutica cuya misión es mejorar la vida humana desarrollando nuevas medicinas y productos para el cuidado de la salud
Bristol-Myers Squibb
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. By pursuing this mission, we are ...
BMY: Summary for BRISTOL-MYERS SQUIBB - Yahoo! Finance
Get detailed information on BRISTOL-MYERS SQUIBB (BMY) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
BMY - Bristol-Myers Squibb Co Stock quote - CNNMoney.com
Bristol-Myers Squibb Company was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business ...
Bristol-Myers Squibb Company - New York NY United States - Company ...
Bristol-Myers Squibb Company Company Profile - View the latest news, market research, credit research, and investment research on Bristol-Myers Squibb Company New York NY United ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about BristolMyers

Bristol-Myers Squibb (nyse: BMY), colloquially referred to as BMS, is a pharmaceutical company. Founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were graduates of Hamilton College), Bristol-Myers merged with Squibb Corporation in 1989. James M. Cornelius is the New York City-based company's Chairman and CEO and was granted $25.0 million in compensation in 2008 according to Forbes.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention BristolMyers
Early Glance: Pharmaceuticals companies
AP via Yahoo! Finance
NEW YORK (AP) -- Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter fell $.04 or .1 percent, to $54.57. Bristol-Myers Squibb fell $.03 or .1 percent, to $22.09. Hospira fell $.45 or 1.0 percent, to $46.66. Johnson & J...
Lawyer in landmark breast implant lawsuits dies
YAHOO!
By 1992, he began a long run of silicone breast-implant lawsuits with a $25 million verdict against Bristol-Myers Squibb. O'Quinn ... Related Searches: bristol-myers squibb tobacco industry law firm
Early Glance: Pharmaceuticals companies
INO News
(AP:NEW YORK) Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter fell $.22 or .4 percent, to $54.31. Bristol-Myers Squibb rose $.04 or .2 percent, to $22.20.
Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in ...
Stockhouse
--Raises 2009 GAAP EPS Guidance to $1.72 to $1.77; Refines 2009 Non-GAAP EPS Guidance to $2.00 to $2.05; Reiterates Minimum Expected 15% Non-GAAP 2007-2010 EPS CAGR Bristol-Myers Squibb Company (NYSE:BMY) today reported strong sales and ear...
ZymoGenetics Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb
BioresearchOnline
ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced the initiation of a Phase 2 clinical trial of PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection (the "EMERGE" study).
AstraZeneca quarterly earns up 22 percent
Miami Herald
Onglyza, the diabetes drug AstraZeneca launched with Bristol-Myers Squibb Co., booked AstraZeneca revenue of $9 million in the quarter. Seroquel sales were up 12 percent at $1.23 billion over the quarter. The Philadelphia inquiry included a...
AstraZeneca Probes Aspirin Impact on Brilinta’s Effectiveness
Bloomberg
AstraZeneca’s Brilinta beat Sanofi-Aventis SA and Bristol- Myers Squibb Co.’s blood thinner Plavix in a study, preventing 16 percent more heart attacks, strokes and deaths. The trial included more than 18,000 patients in 43 countries. Those...
Final Glance: Pharmaceuticals companies
AP via Yahoo! Finance
NEW YORK (AP) -- Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter fell $.46 or .8 percent, to $54.61. Bristol-Myers Squibb rose $.20 or .9 percent, to $22.12. Hospira rose $.81 or 1.7 percent, to $47.1...
UPDATE 2-Bristol earnings edge past views, helped by costs
Reuters
NEW YORK, Oct 22 (Reuters) - Bristol-Myers Squibb Co on Thursday ( BMY.N ) posted third-quarter profit slightly ahead of analyst estimates, helped by cost controls, and raised the low end of its full-year earnings forecast. Net income attri...
US Drug Makers 3Q Helped By Cost Cuts, Major Product Sales
CNN Money
U.S. drug makers Merck & Co. (MRK) and Bristol-Myers Squibb Co. (BMY) reported higher third-quarter sales and earnings from continuing operations, helped by reduced costs and higher revenue from major products. Schering-Plough Corp. (SGP) r...